fda deadline tirzepatide is semaglutide on shortage list taken off As of February 21, 2025, the updated its drug list Semaglutide and off FDA – FDA says shortage of GLP-1

Supplemental protein in support of muscle mass and health: advantage whey

If you struggle with consistency, set a phone reminder for your scheduled injection day, mark it on a calendar, or ask a family member to help you remember

If dietary intake remains insufficient, a magnesium supplement of 200400 mg daily may be beneficial, though patients should consult their healthcare provider about timing and form

Tirzepatide is a first-in-class T2D medication that activates both the GIP and GLP-1 receptors to help patients better manage blood sugar, while triggering weight loss and improving lipid markers

It is particularly used to treat type II diabetes

The tirzepatide dose chart can help map this to syringe volumes